Coya Therapeutics Reports Encouraging Interim Results in Frontotemporal Dementia Study
Coya Therapeutics reports promising interim results from a study on a novel treatment for frontotemporal dementia, a neurodegenerative disease affecting millions worldwide.
2 minutes to read